Product: Anagrelide Capsules USP, 0.5 mg,  100-count bottles, Rx Only, Manufactured in India For: TEVA PHARMACEUTICALS USA, Inc., North Wales, PA 19454. NDC 0172-5241-60.
Reason for recall: Failed Dissolution Specifications- Low Out-Of-Specification results obtained during stability testing.
Recall initiated: 20220511
Status: Terminated
Classification: Class I
Recall type: Voluntary: Firm initiated